article Open AccessTop 1% cited
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
The Lancet Infectious Diseases · 2020 · Vol. 21(2) · pp. 181–192
Yanjun Zhang✉(Zhejiang Center for Disease Control and Prevention)Gang Zeng(Sinovac Biotech)Hongxing Pan(Jiangsu Provincial Center for Disease Control and Prevention)Changgui Li(National Institutes for Food and Drug Control)Yaling Hu(Sinovac Biotech)Kai Chu(Jiangsu Provincial Center for Disease Control and Prevention)Weixiao Han(Sinovac Biotech)Zhen Chen(National Institutes for Food and Drug Control)Rong Tang(Jiangsu Provincial Center for Disease Control and Prevention)Weidong Yin(Sinovac Biotech)Xin Chen(Suizhou Central Hospital)Yuansheng Hu(Sinovac Biotech)Xiaoyong Liu(Suizhou Central Hospital)Congbing Jiang(Suizhou Central Hospital)Jingxin Li(Jiangsu Provincial Center for Disease Control and Prevention)Minnan Yang(Chinese Academy of Sciences)Yan Song(Suizhou Central Hospital)Xiangxi Wang(Chinese Academy of Sciences)Qiang GaoFengcai Zhu(Jiangsu Provincial Center for Disease Control and Prevention)
SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and HesitancyCOVID-19 Clinical Research StudiesMedicineTolerabilityPlaceboVaccinationCohortClinical trialInternal medicineRandomized controlled trialAdverse effectImmunology
MeSH terms
SeroconversionImmunogenicity, VaccineCOVID-19SARS-CoV-2COVID-19 VaccinesAdolescentAdultAntibodies, ViralChinaFemaleHumansImmunoglobulin GImmunoglobulin MImmunization ScheduleMale
Funding
- Ministry of Science and Technology of the People's Republic of China
- Beijing Municipal Science and Technology Commission
- National Key Research and Development Program of China
Citations
1,500
FWCI
33.66
field-weighted impact
References
28
Percentile
100%
vs. same field & year
Citations per year
Cited by
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine
New England Journal of Medicine · 2020 · 10,528 citations
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
Nature Medicine · 2021 · 4,152 citations
References
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2
Emerging infectious diseases · 2020 · 1,632 citations
Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial
The Lancet Infectious Diseases · 2020 · 1,207 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.